 |
The Journal of Neuroscience, November 3, 2004, 24(44):9944-9952; doi:10.1523/JNEUROSCI.2856-04.2004
Previous Article | Next Article 
Cellular/Molecular
Macrophage Migration Inhibitory Factor: An Intracellular Inhibitor of Angiotensin II-Induced Increases in Neuronal Activity
Chengwen Sun,1
Hongwei Li,1
Lin Leng,2
Mohan K. Raizada,1
Richard Bucala,2 and
Colin Sumners1
1Department of Physiology and Functional Genomics and McKnight Brain Institute, University of Florida, Gainesville, Florida 32610-0274, and 2Yale University School of Medicine, New Haven, Connecticut 06520-8031
Angiotensin II (Ang II) elicits Ang II type 1 receptor (AT1-R)-mediated increases in neuronal firing within the hypothalamus and brainstem that are ultimately responsible for physiological actions such as increased blood pressure and fluid intake. Although there is a growing literature on the intracellular mechanisms that mediate the actions of Ang II via AT1-R in neurons, little is known about the mechanisms that diminish or "switch-off" the neuronal chronotropic action of Ang II. In the present study, we identified macrophage migration inhibitory factor (MIF) as an intracellular inhibitor of the actions of Ang II in neurons. The evidence is as follows. First, Ang II, acting via AT1-R, increases the intracellular levels of MIF in neurons cultured from rat hypothalamus and brainstem. Second, elevation of intracellular MIF by Ang II prevents further chronotropic actions of this peptide. Third, intracellular application of exogenous recombinant MIF abolishes the Ang II-induced chronotropic action in neurons. Finally, intracellular application of the MIF peptide fragment MIF-(50-65), which harbors the thiol oxidoreductase property of the MIF molecule, mimics the inhibitory actions of MIF on Ang II-stimulated neuronal firing. Thus, this study is the first to demonstrate the existence of an intracellular negative regulator of Ang II-induced actions in neurons and indicates that MIF may act as a physiological brake for the chronotropic effects of Ang II in rat neurons.
Key words: angiotensin II; macrophage migration inhibitory factor; neuron; firing rate; thiol-protein oxidoreductase; reactive oxygen species
Received April 15, 2004;
revised September 24, 2004;
accepted September 27, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
E. L. Grigorenko, S. S. Han, C. M. Yrigollen, L. Leng, Y. Mizue, G. M. Anderson, E. J. Mulder, A. de Bildt, R. B. Minderaa, F. R. Volkmar, et al.
Macrophage Migration Inhibitory Factor and Autism Spectrum Disorders
Pediatrics,
August 1, 2008;
122(2):
e438 - e445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kurihara, Y. Ozawa, N. Nagai, K. Shinoda, K. Noda, Y. Imamura, K. Tsubota, H. Okano, Y. Oike, and S. Ishida
Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina
Diabetes,
August 1, 2008;
57(8):
2191 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yao, C. Sumners, S. T. O'Rourke, and C. Sun
Angiotensin II increases GABAB receptor expression in nucleus tractus solitarii of rats
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2712 - H2720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield
Angiotensin II and Its Receptor Subtypes in the Human Retina
Invest. Ophthalmol. Vis. Sci.,
July 1, 2007;
48(7):
3301 - 3311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuura, R. A. Harrison, A. D. Westwell, H. Nakamura, A. E. Martynyuk, and C. Sumners
Basal and angiotensin II-inhibited neuronal delayed-rectifier K+ current are regulated by thioredoxin
Am J Physiol Cell Physiol,
July 1, 2007;
293(1):
C211 - C217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sun, H. Li, Y. Gao, T. Matsuura, P. A. Upchurch, M. K. Raizada, and C. Sumners
Lack of Macrophage Migration Inhibitory Factor Regulation Is Linked to the Increased Chronotropic Action of Angiotensin II in SHR Neurons
Hypertension,
March 1, 2007;
49(3):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kurihara, Y. Ozawa, K. Shinoda, N. Nagai, M. Inoue, Y. Oike, K. Tsubota, S. Ishida, and H. Okano
Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal Inflammation
Invest. Ophthalmol. Vis. Sci.,
December 1, 2006;
47(12):
5545 - 5552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, Y. Gao, C. D. Freire, M. K. Raizada, G. M. Toney, and C. Sumners
Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II
FASEB J,
August 1, 2006;
20(10):
1748 - 1750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuura, C. Sun, L. Leng, A. Kapurniotu, J. Bernhagen, R. Bucala, A. E. Martynyuk, and C. Sumners
Macrophage Migration Inhibitory Factor Increases Neuronal Delayed Rectifier K+ Current
J Neurophysiol,
February 1, 2006;
95(2):
1042 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|